:: Library Catalog

Cover Image

Saved in:

Bibliographic Details
Main Authors:	Liao Hangyu, Pan, Mingxin, Zhao, Liang
Format:	Recurso digital
Language:
Published:	Zenodo 2026
Online Access:	https://doi.org/10.5281/zenodo.19396187
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Steroid‐Refractory Cryptogenic Organising Pneumonia ( COP ) in a Patient With Mannose‐Binding Lectin ( MBL ) Deficiency
by: Ilias E. Dimeas, et al.
Published: (2026)

Analysis of Mannose‐Binding Lectin Protein and mRNA Levels on Selected Chicken Breeds in South Africa
by: Peter Ayodeji Idowu, et al.
Published: (2024)

The TRIM27 / STING Axis Mediates Schisandrin B‐Induced Inhibition of Myeloid‐Derived Suppressor Cells Accumulation to Potentiate Anti‐ PD ‐1 Immunotherapy in Hepatocellular Carcinoma
by: Lei Huang, et al.
Published: (2026)

Targeting Caveolin‐1 in Multiple Myeloma Cells Enhances Chemotherapy and Natural Killer Cell‐Mediated Immunotherapy
by: Dewen Zhan, et al.
Published: (2024)

Natural Killer Cells: Angels and Devils for Immunotherapy
by: Martin Antonio, Beatriz, et al.
Published: (2017)

m 6 A‐Mediated TMCO3 Promotes Hepatocellular Carcinoma Progression by Facilitating the Membrane Translocation and Activation of AKT
by: Xinxin Li, et al.
Published: (2025)

Transparency and Reporting in the Evaluation of PD1 by Flow Cytometry
by: Marc Sorigue, et al.
Published: (2025)

Aligned Fibronectin Microenvironment Temporally Facilitates Profibrotic Fibroblast Activation via Integrin α5β1
by: Doğuhan Beyatlı, et al.
Published: (2026)

Elemene Augments the Effects of Anti‐PD‐1 Immunotherapy on Hepatocellular Carcinoma by Regulating the miR‐130a‐5p/SPP/MHC‐I Axis
by: Menglan Wang, et al.
Published: (2026)

T Cell Exhaustion in Hepatocellular Carcinoma: A Substantial Barrier in Immunotherapy
by: Kosar Nouri, et al.
Published: (2026)

Biomimetic Nanomedicine for Senescence‐Modulated Immune Activation Enhances Immunotherapy Efficacy in Hepatocellular Carcinoma
by: Shiji Fang, et al.
Published: (2025)

Antibody‐Targeted Artificial T Cell and Natural Killer Cell Derived Vesicles for Cancer Immunotherapy
by: Brijesh Parlekar, et al.
Published: (2026)

Integrin β4‐Enriched Small Extracellular Vesicle as Drug Delivery Vehicle for Targeting Pulmonary Metastasis of Hepatocellular Carcinoma
by: Tung Him Ng, et al.
Published: (2025)

Clinical Significance of PD ‐ L1 and HLA Expression in Esophageal Squamous Cell Carcinoma in Response to Immunotherapy
by: Kosuke Kanemitsu, et al.
Published: (2026)

Restricted Expression of the Constant Region 1 of T‐Cell Receptor β by Flow Cytometry Facilitates Detection of T‐Cell Neoplasms With High Specificity but Moderate Predictive Value
by: Nilofar Rajabian, et al.
Published: (2025)

Variantes del gen Mannose Binding Lectin (MBL) en pobladores amazónicos de Andoas-Loreto y su posible implicancia en la salud
by: Alberto Salazar Granara
Published: (2006)

PLAUR + Neutrophils Drive Anti‐PD‐1 Therapy Resistance in Patients with Hepatocellular Carcinoma by Shaping an Immunosuppressive Microenvironment
by: Shaoqing Liu, et al.
Published: (2025)

Nanoparticle‐Mediated Explosive Anti‐PD‐L1 Factory Built in Tumor for Advanced Immunotherapy
by: Mihyeon Park, et al.
Published: (2025)

LncRNA FGD5‐AS1 Facilitates Hepatocellular Carcinoma Cell Stemness by Enhancing PKD1 mRNA Stability Through Binding With MSI2
by: Chenkun He, et al.
Published: (2025)

RETRACTION: The Cell Surface GRP78 Facilitates the Invasion of Hepatocellular Carcinoma Cells
by: BioMed Research International
Published: (2025)

Targeting Intratumoral Copper Inhibits Tumor Progression via p62‐Mediated EZH2 Degradation and Potentiates Anti‐PD‐1 Immunotherapy in Oral Squamous Cell Carcinoma
by: Xiaohu Lin, et al.
Published: (2025)

Deciphering the Interference of the Anti‐Integrin α4β7 Vedolizumab With Cell Crossmatch
by: Marine Cargou, et al.
Published: (2025)

Supplementary mateirials for 'PPIL1 Drives Hepatocellular Carcinoma Progression and Cancer Stem Cell Self-Renewal through DAAM2-Mediated Wnt/β-Catenin Activation'
by: Wu, Jiayi
Published: (2026)

Astragaloside IV Enhances Anti‐PD‐L1 Immunotherapy in Triple‐Negative Breast Cancer by Activating the cGAS‐STING Pathway
by: Chuanchao Wei, et al.
Published: (2026)

Effects of Splenectomy on Natural Killer Cell Levels in β‐Thalassemia Major Patients
by: Ayşegül Uğur Kurtoğlu, et al.
Published: (2024)

PD‐L1 on Tumor‐Derived Extracellular Vesicles Induces CD8 + T Cell Terminal Exhaustion and Mediates Anti‐PD‐1 Resistance in Head and Neck Squamous Cell Carcinoma
by: Ruihua Fang, et al.
Published: (2025)

Light‐Controlled Bioorthogonal Chemistry Altered Natural Killer Cell Activity for Boosted Adoptive Immunotherapy
by: Zhengwei Liu, et al.
Published: (2024)

Treatment Patterns and Clinical Outcomes After Immunotherapy Failure in Patients With Natural Killer/T‐Cell Lymphoma
by: Shenrui Bai, et al.
Published: (2026)

Light‐Controlled Bioorthogonal Chemistry Altered Natural Killer Cell Activity for Boosted Adoptive Immunotherapy
by: Zhengwei Liu, et al.
Published: (2024)

NQO1/p65/CXCL12 Axis‐Recruited Tregs Mediate Resistance to Anti‐PD‐1 Plus Lenvatinib Therapy in PIVKA‐II‐Positive Hepatocellular Carcinoma
by: Biao Gao, et al.
Published: (2025)

Integrated Computational Modelling and Proteomic Profiling of Banana Lectin Isoforms Recognizing Cancer-Associated High-Mannose N-Glycans
by: Kurniawan, Hansley
Published: (2026)

Selective Suppression of Integrin‐Ligand Binding by Single Molecular Tension Probes Mediates Directional Cell Migration
by: Seong‐Beom Han, et al.
Published: (2024)

MMRN1 Facilitates Renal Cell Carcinoma by Activating AMPK / MMPs Axis
by: Mingji Ye, et al.
Published: (2025)

Natural Killer Cell‐Mediated Antitumor Immunity: Molecular Mechanisms and Clinical Applications
by: Nanzhi Luo, et al.
Published: (2025)

Y‐Box‐Binding Protein 1 Facilitates the Proliferation and Osteogenic Differentiation of Periodontal Ligament Stem Cells Through the Transcriptional Activation of FGF2 ‐Mediated Akt/ GSK3β /β‐Catenin Signaling
by: Yun‐Hao Xi, et al.
Published: (2025)

Targeted Therapy and Immunotherapies in Hepatocellular Carcinoma: Mechanisms and Clinical Studies
by: Penghui He, et al.
Published: (2026)

Gut Microbiota and Hepatocellular Carcinoma: Metabolic Products and Immunotherapy Modulation
by: Kunmin Xiao, et al.
Published: (2025)

Icaritin Sensitizes Hepatocellular Carcinoma to PD ‐ L1 Therapy by NQO1 ‐Dependent Ferroptosis Induction
by: Zhen Li, et al.
Published: (2026)

Activatable Fluorescence/Photoacoustic Macromolecular Probe for Imaging of Tumor‐Associated Natural Killer Cells
by: Yanbin Feng, et al.
Published: (2025)

Mannose Promotes β‐Amyloid Pathology by Regulating BACE1 Glycosylation in Alzheimer's Disease
by: Chensi Liang, et al.
Published: (2025)